
Dejero is working on networks that enable internet connectivity in remote locations and secured the backing of Intelsat as a strategic partner.
GV has participated in a series D round for Fractyl Laboratories, which is developing minimally-invasive treatment for metabolic diseases.
GV returned for the round, as did Acre Venture Partners, after both previously backed a $40m series C this past March.
Real Ventures has secured capital from limited partners including Tencent and Singapore state-owned investment firm Temasek for funds aimed at Montreal and wider Canada.
AG Insurance and Flemish government-owned PMV have committed to be cornerstone investors in the fund, which has achieved a $150m close.
Alexandria Venture Investments was among the investors in a series C round for Codiak Biosciences, based on research at Gothenburg and Texas universities.
The round, backed by Illumina Ventures, brought in $10m in funding though some of that amount was in the form of convertible notes.
Cigna, Guardian Life Insurance, Hikma and Merck are part of a consortium that has provided $20.5m in series C funding to healthcare-focused AI software developer Prognos.